Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb) — Tarek Meniawy (2017) | RDL Network
Preliminary results from a subset of patients (pts) with advanced ovarian cancer (OC) in a dose-escalation/expansion study of BGB-A317, an anti-PD-1 monoclonal antibody (mAb)
Jayesh Desai, Ben Markman, Shahneen Sandhu, Hui Gan, Michael Friedlander, Ben Tran, Tarek Meniawy, Vishal Boolell, Duncan Colyer, Christie Norris, Malaka Ameratunga, Jason Yang, Kang Li, Lai Wang, Lusong Luo, Zhen Qin, Michael Millward
Shahneen Sandhu, Andrew G. Hill, Hui Gan, Michael Friedlander, Mark Voskoboynik, Paula Barlow, Amanda Townsend, James Song, Yun Zhang, Zhirong Shen, Qinzhou Qi, Jayesh Desai
Shahneen Sandhu, Andrew G. Hill, Hui Gan, Michael Friedlander, Mark Voskoboynik, Paula Barlow, Amanda Townsend, Juhee Song, Y. Zhang, Li Liang, Jayesh Desai
Eben I. Lichtman, Amit Khot, Bradley Augustson, David Levitz, Hanlon Sia, Nicole Wong Doo, Michaela Liedtke, Camille Martinet, Vinu Menon, Andrew Garton, Harjeet Sembhi, Maria Pihlgren, Cyril Konto, Beata Holkova, Lida Pacaud, Hang Quach
Discussion(0)
No comments yet. Be the first to comment.